A CONVENIENT PROCEDURE FOR THE SYNTHESIS OF 6-O-MONO-PHOSPHATE 1679
12. Singh, S.; Das, G.; Singh, O. V.; Han, H. Tetrahedron Lett. 2007, 48, 1983-1986.
13. Loannou, P. V.; Tsivgoulis, G. M. Chem. Phys. Lipids 2010, 63, 51-55.
14. Synthesis of 6-O-mono-phosphate β-Cyclodextrin Materials: DMF was dried by distilling over
calcium hydride under reduced pressure. β-cyclodextrin was dried by heating at 65◦C for 24 h
under vacuum. Other reagents were obtained from Sigma Aldrich and they were used without
further purification. All the reactions were carried out under argon. General procedure: To a
solution of β-cyclodextrin (5 g, 4.41 mmol) and DMAP (0.298 g, 2.44 mmol) in DMF (100 mL),
dialkyl (or diaryl) chlorophosphate (0.761 g, 4.41 mmol) in DMF (50 mL) was added drop-wise
under argon. The reaction was stirred at room temperature for 4 d under argon. The solvent was
removed from the reaction mixture under reduced pressure, and the residue was triturated with
diethyl ether (100 mL) and stirred for 2 d. The obtained suspension was filtrated and washed
5 times with isopropanol (80 mL). The product was dried at room temperature under vacuum to
give the title compound. Instruments: 1H, 13C, and 31P NMR spectra were recorded at 300 MHz on
a Varian Gemini-300 Spectrometer or at 400 MHz on a Bruker Avance Spectromer in dimethyl
sulfoxide (DMSO-d6) or dimethyl formamide (DMF-d7). FT-IR spectra were obtained on a
Perkin Elmer Spectrum 100 spectrometer. (2a) (2.34 g, 69%). FT-IR ν (cm−1) 3291, 2896, 1651,
1565, 1409, 1327, 1294, 1251, 1223, 1153, 1102, 1079, 1025, 999, 938, 854, 755, 7036. 1H NMR
(DMSO-d6) δ 5.70 broad (m, 14H, OH-2, OH-3), 4.81 (s, 7H, H-1), 4.20–3.42 (m, 41H, OCH3,
H-6, H-5, H-3, H2O), 3.36–2.71 (m, 23H, H-4, H-2, OH-6).13C NMR (DMF-d7) δ 103.2 (C-1),
82.8 (C-4), 74.1 (C-3), 73.7 (C-5), 73.1 (C-2), 63.2 (OCH3), 61.2 (C-6).31P NMR (DMSO-d6) δ
1.1. Found: C, 39.92; H, 6.27. Calc. For C44H75O38P.5H2O: C, 39.63; H, 6.38%. (2b) (4.90 g,
85%). FT-IR: ν (cm−1) 3286, 2924, 1703, 1658, 1404, 1364, 1328, 1294, 1253, 1223, 1153, 1079,
1026, 1000, 938, 846, 795, 753, 703. 1H NMR (DMSO-d6) δ 5.76–5.71 (m, 14H, OH-2, OH-3,),
4.81 (s, 7H, H-1), 4.47 (m, 4H, OCH2-), 3.64–3.53 (m, 34H, H-6, H-5, H-3, H2O), 3.35–3.28
(m, 21H, H-4, H-2, OH-6), 1.18–1.10 (m, 6H, CH3). 13C NMR (DMF-d7): δ 103.2 (C-1), 82.9
(C-4), 74.2 (C-3), 73.80 (C-5), 73.2 (C-2), 61.3–61.0 (OCH2,C-6, C-6’), 16.8–16.7 (CH3).31P
NMR (DMSO-d6) δ -0.9. Found: C, 40.49; H, 6.47. Calc. For C46H79O38P.5H2O: C, 40.58; H,
6.54%. (2c) (4.10 g, 70%). FT-IR ν (cm−1) 3301, 2926, 1659, 1411, 1362, 1328, 1296, 1241,
1154, 1080, 1027, 1000, 937, 890, 846, 795, 754, 706. 1H NMR (DMSO-d6) δ 5.18 broad (m,
20H, OH-2, OH-3, OH-6), 4.81–4.08 (m, 7H, H-1), 3.79–3.04 (m, 52H, OCH(CH3)2, H-6, H-5,
H-3, H-4, H-2, H2O), 1.18–1.11 (m, 12H OCH(CH3)2).13C NMR (DMF-d7) δ 103.2 (C-1), 82.8
(C-4), 74.2 (C-3), 73.7 (C-5), 73.2 (C-2), 61.3 (C-6), 24.3–24.2 (CH3). 31P NMR (DMSO-d6) δ
1.0.. Found: C, 40.77; H, 6.25. Calc. For C52H83O38P.10H2O: C, 40.89; H, 6.01%. (2d)(8) (2.42 g,
60%). FT-IR ν (cm−1) 3284, 2914, 1649, 1592, 1490, 1413, 1368, 1330, 1300, 1247, 1195, 1154,
1098, 1079, 1024, 1000, 937, 862, 753, 702, 686; 1H NMR (DMSO-d6) δ 7.26 – 6.94 (m, 10H,
Ar), 5.69 broad (m, 20H, OH-2, OH-3, OH-6), 4.80 (s, 7H, H-1), 3.65–3.16 (m, 62H, H-6, H-5,
H-3, H-4, H-2, H2O); 13C NMR (DMF-d7) δ 129.7, 123.3, 120.7–120.6 (phenyl), 103.2 (C-1),
82.8 (C-4), 74.1 (C-3), 73.7 (C-5), 73.1 (C-2), 61.2 (C-6); 31P NMR (DMSO-d6) δ -11.5 .Found:
C, 41.75; H, 6.60. Calc. For C54H79O38P.10H2O: C, 41.91; H, 6.40%.
15. Vervoort, L.; Van den Mooter, G.; Augustijns, P.; Busson, R.; Toppet, S.; Kinget, R. Pharm. Res.
1997, 14, 1730-1737.